New cardinal health surgical drape helps reduce surgical site contamination risk

The incise drape is the first to feature avery dennison's patented benehold™ chg adhesive technology  dublin, ohio, march 17, 2022 /prnewswire/ -- cardinal health (nyse: cah) today launched the first surgical incise drape using industry-leading antiseptic chlorhexidine gluconate (chg). the drape features avery dennison's patented benehold™ chg adhesive technology, which helps reduce the risk of surgical site contamination with organisms typically associated with surgical site infections (ssis).
CAH Ratings Summary
CAH Quant Ranking